Table 2 Angiographic and procedural finding of the patients with STEMI stratified by the presence of hyperuricemia
Characteristics | Patients with hyperuricemia | Patients without hyperuricemia | p value |
|---|---|---|---|
(n = 147) | (n = 487) | ||
Serum uric acid 8.9 (7.1–8.9) mg/dl | Serum uric acid 5.0 (4.1–5.7) mg/dl | ||
Angiographic | |||
IRA | |||
Left anterior descending | 79 (53.7%) | 244 (50.1%) | 0.439 |
Left circumflex | 8 (5.4%) | 69 (14.2%) | 0.005 |
Right coronary artery | 57 (38.8%) | 175 (35.9%) | 0.531 |
Left main | 5 (3.4%) | 0 (0%) | 0.001 |
Two IRAs | 2 (1.4%) | 1 (0.2%) | 0.136 |
ST-related myocardial infarction | 3 (2.0%) | 11 (2.3%) | 1.000 |
Diseased vessels | |||
1 | 37 (25.2%) | 136 (27.9%) | 0.511 |
2 | 50 (34.0%) | 154 (31.6%) | 0.586 |
3 | 60 (40.8%) | 197 (40.5%) | 0.937 |
TIMI 0 flow before PPCI | 107 (72.8%) | 327 (67.1%) | 0.197 |
Procedural | |||
Total ischemic time (hour) | 6.0 (3.0–12.0) | 6.0 (4.0–12.0) | 0.407 |
Thrombus aspiration | 108 (73.5%) | 329 (67.6%) | 0.175 |
Glycoprotein IIb/IIIa inhibitor | 47 (32.0%) | 154 (31.6%) | 0.936 |
Predilation | 131 (89.1%) | 414 85.0%) | 0.123 |
Predilation balloon diameter (mm) | 2.3 ± 0.3 | 2.3 ± 0.3 | 0.696 |
Predilation balloon length (mm) | 15.2 ± 2.9 | 15.7 ± 3.0 | 0.120 |
Stent number | 1.3 ± 0.5 | 1.2 ± 0.5 | 0.116 |
Stent diameter (mm) | 3.2 ± 0.4 | 3.2 ± 0.6 | 0.931 |
Stent length (mm) | 32.4 ± 15.5 | 30.1 ± 16.6 | 0.151 |
Postdilation | 58 (39.5%) | 195 (40.0%) | 0.965 |
Postdilation balloon diameter (mm) | 3.3 ± 0.5 | 3.4 ± 0.4 | 0.743 |
Postdilation balloon length (mm) | 12.7 ± 2.6 | 12.8 ± 2.4 | 0.839 |
Postdilation pressure (Atm) | 16.6 ± 4.2 | 16.9 ± 3.2 | 0.665 |
Intra-aortic balloon pump | 7 (4.8%) | 8 (1.6%) | 0.055 |
SVT/VF during PPCI | 6 (4.1%) | 6 (1.2%) | 0.037 |
No-reflow | 9 (6.1%) | 12 (2.5%) | 0.036 |
TIMI 3 flow after PPCI | 144 (98.0%) | 482 (98.0%) | 0.396 |